<DOC>
	<DOCNO>NCT00003384</DOCNO>
	<brief_summary>This diagnostic trial study presence specific protein potential biomarker cervical dysplasia and/or cancer . The presence specific protein may allow doctor determine whether patient cervical dysplasia and/or cancer .</brief_summary>
	<brief_title>Protein Expression Potential Diagnostic Biomarker Cervical Dysplasia and/or Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate utility MN protein , novel tumor-associated antigen , potential diagnostic biomarker cervical glandular and/or squamous neoplasia patient cytologic diagnosis atypical glandular cell undetermined significance ( AGUS ) . II . Measure frequency type cervical pathology associate diagnosis AGUS patient . III . Determine whether presence high-risk type human papilloma virus ( HPV ) ThinPrep cervical cell specimen predict presence cervical glandular and/or squamous cell neoplasia patient . IV . Determine relationship MN antigen expression presence high-risk HPV patient . OUTLINE : This multicenter study . Patients undergo Pap smear follow ThinPrep cervical cell specimen collection time direct colposcopic examination . Patients undergo cone biopsy cervix use loop electrosurgical excision procedure endocervical curettage , excisional cone biopsy cervix without endocervical curettage , hysterectomy . Patients perimenopausal postmenopausal negative cervical cone biopsy also undergo endometrial biopsy curettage . The Pap smear specimen analyze determine MN antigen expression ThinPrep specimen analyze presence high-risk human papilloma virus determine MN antigen marker ( e.g. , P16 ) expression . Patients undergo hysterectomy follow every 6 month 2 year . All patient follow 4 , 26 , 30 week .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>Cytologically confirm atypical glandular cell undetermined significance ( AGUS ) Must schedule undergo complete histologic examination cervix cone biopsy use loop electrosurgical excision procedure endocervical curettage , excisional cone biopsy without endocervical curettage , hysterectomy within 6 month initial cytologic diagnosis AGUS No history endometrial hyperplasia No history cancer endometrium , vagina , cervix HIV negative No pregnant patient high risk excessive bleed preterm labor cone biopsy perform No prior cytotoxic chemotherapy vaginal and/or cervical cancer No prior radiotherapy vagina cervix No concurrent radiotherapy vagina cervix No prior hysterectomy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>